The role of postoperative radiotherapy in pN1 oral cavity cancer without extranodal extension.
Extranodal extension
N1
Oral cancer
Radiotherapy
Journal
World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544
Informations de publication
Date de publication:
17 Sep 2021
17 Sep 2021
Historique:
received:
19
07
2021
accepted:
06
09
2021
entrez:
18
9
2021
pubmed:
19
9
2021
medline:
22
9
2021
Statut:
epublish
Résumé
The administration of postoperative radiotherapy remains controversial in pN1 oral cavity cancer patients without extranodal extension. The aim is to determine whether postoperative radiotherapy reduces the neck recurrence rate and improves the survival outcomes of pN1 patients. This study consecutively enrolled 1056 patients with newly diagnosed oral squamous cell carcinoma who underwent tumor wide excision and neck dissection from September 2002 to November 2019. One hundred two pN1 patients without extranodal extension were eligible for analysis. Then, a subgroup analysis of 40 patients was performed after patients with other adverse risk factors (positive margins, close margins, lymphovascular invasion, perineural invasion, tumor depth ≥ 10 mm, and poor histological differentiation) were excluded. Of the 102 eligible pN1 patients, 26 patients received surgery alone, and 76 received postoperative radiotherapy. No significant differences were observed in the neck recurrence rate (7.7% vs. 15.8%, p = 0.30). Similarly, in patients without other adverse risk factors, no significant differences were observed in the neck recurrence rate (5% vs. 20%, p = 0.15) between surgery alone group and postoperative radiotherapy group. Moreover, no significant difference was found in the neck recurrence-free survival rate, overall survival, and disease-specific survival (77.1% vs. 52.5%, p = 0.42, 83.5% vs. 64.5%, p = 0.81, and 88.2% vs. 67.9%, p = 0.34, respectively). Postoperative radiotherapy did not significantly decrease the probability of neck recurrence and survival outcomes in pN1 patients without extranodal extension. Radical surgery alone may be considered sufficient treatment for pN1 patients without other adverse risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
The administration of postoperative radiotherapy remains controversial in pN1 oral cavity cancer patients without extranodal extension. The aim is to determine whether postoperative radiotherapy reduces the neck recurrence rate and improves the survival outcomes of pN1 patients.
METHODS
METHODS
This study consecutively enrolled 1056 patients with newly diagnosed oral squamous cell carcinoma who underwent tumor wide excision and neck dissection from September 2002 to November 2019. One hundred two pN1 patients without extranodal extension were eligible for analysis. Then, a subgroup analysis of 40 patients was performed after patients with other adverse risk factors (positive margins, close margins, lymphovascular invasion, perineural invasion, tumor depth ≥ 10 mm, and poor histological differentiation) were excluded.
RESULTS
RESULTS
Of the 102 eligible pN1 patients, 26 patients received surgery alone, and 76 received postoperative radiotherapy. No significant differences were observed in the neck recurrence rate (7.7% vs. 15.8%, p = 0.30). Similarly, in patients without other adverse risk factors, no significant differences were observed in the neck recurrence rate (5% vs. 20%, p = 0.15) between surgery alone group and postoperative radiotherapy group. Moreover, no significant difference was found in the neck recurrence-free survival rate, overall survival, and disease-specific survival (77.1% vs. 52.5%, p = 0.42, 83.5% vs. 64.5%, p = 0.81, and 88.2% vs. 67.9%, p = 0.34, respectively).
CONCLUSION
CONCLUSIONS
Postoperative radiotherapy did not significantly decrease the probability of neck recurrence and survival outcomes in pN1 patients without extranodal extension. Radical surgery alone may be considered sufficient treatment for pN1 patients without other adverse risk factors.
Identifiants
pubmed: 34535149
doi: 10.1186/s12957-021-02396-y
pii: 10.1186/s12957-021-02396-y
pmc: PMC8449449
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
279Subventions
Organisme : chang gung memorial hospital, linkou
ID : CMRPG3J1252 and CMRPG3H0853
Organisme : ministry of science and technology, taiwan
ID : MOST 108-2314-B-182A-108-MY3
Informations de copyright
© 2021. The Author(s).
Références
Head Neck. 1999 Sep;21(6):499-505
pubmed: 10449664
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1224-1230
pubmed: 27832255
World J Surg Oncol. 2007 Jan 30;5:12
pubmed: 17263872
World J Surg Oncol. 2018 Nov 8;16(1):219
pubmed: 30409212
Laryngoscope. 2020 Oct;130(10):E530-E538
pubmed: 31837151
Otolaryngol Head Neck Surg. 2001 Feb;124(2):180-7
pubmed: 11226954
World J Surg Oncol. 2018 Jan 31;16(1):20
pubmed: 29386013
Am J Surg. 1986 Oct;152(4):345-50
pubmed: 3766861
World J Surg Oncol. 2021 Aug 12;19(1):240
pubmed: 34384424
J Oral Maxillofac Surg. 2008 Aug;66(8):1570-9
pubmed: 18634942
Cancer. 2008 Feb 1;112(3):535-43
pubmed: 18076014
Cancer. 2005 Oct 1;104(7):1408-17
pubmed: 16130134
World J Surg Oncol. 2019 Jan 11;17(1):15
pubmed: 30635062
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):284-90
pubmed: 21075550
JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1138-48
pubmed: 25075712
Am J Otolaryngol. 1998 Jan-Feb;19(1):24-8
pubmed: 9470947
Br J Oral Maxillofac Surg. 2004 Jun;42(3):185-9
pubmed: 15121260
Arch Otolaryngol Head Neck Surg. 2010 Mar;136(3):225-8
pubmed: 20231637
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):362-70
pubmed: 18164833
Head Neck. 2008 Jul;30(7):875-82
pubmed: 18302275
Head Neck. 2005 Dec;27(12):1080-91
pubmed: 16240329
Head Neck. 1997 Aug;19(5):400-5
pubmed: 9243267
World J Surg Oncol. 2003 Jul 3;1(1):10
pubmed: 12871595
Head Neck. 1997 May;19(3):205-10
pubmed: 9142520
Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):874-8
pubmed: 16230589
J Oral Maxillofac Surg. 2017 May;75(5):1062-1070
pubmed: 27821247
World J Surg Oncol. 2012 Oct 30;10:227
pubmed: 23110587
J Clin Oncol. 2019 Jul 10;37(20):1753-1774
pubmed: 30811281
Head Neck. 1998 Oct;20(7):588-94
pubmed: 9744457
Head Neck. 2019 Dec;41(12):4136-4142
pubmed: 31589006
World J Surg Oncol. 2019 Nov 27;17(1):198
pubmed: 31775759
Am J Otolaryngol. 2001 Nov-Dec;22(6):395-9
pubmed: 11713724
Head Neck. 2010 May;32(5):555-61
pubmed: 19691114
Laryngoscope. 2012 Dec;122(12):2712-22
pubmed: 23060119
Oral Oncol. 2015 May;51(5):464-9
pubmed: 25716108
J Oral Pathol Med. 2009 Sep;38(8):657-62
pubmed: 19563504
J Surg Oncol. 2018 Jun;117(8):1736-1743
pubmed: 29714825
Int J Oral Maxillofac Surg. 2003 Apr;32(2):167-73
pubmed: 12729777
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593